22.02.2005 22:32:00
|
Unisys and GenuOne to Battle Pharmaceutical Counterfeiting Threats wit
Business Editors/Technology Editors
BLUE BELL, Pa.--(BUSINESS WIRE)--Feb. 22, 2005--
Joint Approach Uses Anti-Counterfeiting, Track and Trace Technologies
to Increase Security and Efficiency
Unisys Corporation (NYSE:UIS) today announced that it has signed an agreement with Boston-based GenuOne, Inc., to help the healthcare and life sciences industries secure their supply chains. GenuOne is a leading provider of product tracking and authentication software.
As part of the agreement, Unisys will leverage GenuOne software in its services to help clients meet imminent regulatory and retail mandates, as well as help clients address additional product safety initiatives and supply chain efficiency opportunities. The joint approach will include applications for electronic pedigree, diversion control and anti-counterfeiting. It is consistent with the federal Prescription Drug Marketing Act (PDMA) requirements and takes into consideration the Florida Laws, California requirements and the Model Rules of the National Association of Boards of Pharmacy (NABP).
"The healthcare and life sciences industries are at a tipping point," said Todd Skrinar, a partner in Unisys Healthcare and Life Sciences practice. "Our clients believe that shrinking the gaps in the extended supply chain, while challenging, ultimately serves the best interest of all partners. They are looking for catalysts to help drive the transformation and we believe Unisys - with the addition of GenuOne's commercially deployed software - is in a unique position to be the driver behind this industry transformation."
As a key component in the company's Global Visible Commerce strategy, the Unisys Guardian Framework supports a mixed environment of RFID technologies, smart barcodes, covert inks and other tagging methods. It integrates with existing enterprise systems that in many cases are not equipped to handle increasingly large volumes of data generated by new tracking technologies.
The Unisys framework includes a portfolio of methods, models and applications for securing supply chains in the consumer product, retail and pharmaceutical industries. It is based on best practices Unisys has learned from over 10 years of experience in regulated environments.
Unisys and GenuOne have integrated a pre-configured template of GenuOne's TraceGuard track and trace software into the Guardian Framework. The template acts as an accelerator for healthcare manufacturers, wholesalers and pharmacies as they pursue patient safety and brand protection initiatives utilizing electronic track and trace capabilities.
"The market convergence of anti-counterfeiting, electronic pedigree and RFID mandates has created a unique opportunity for the life sciences industry to deploy a unified platform to address these issues," said Jeffrey Unger, CEO, GenuOne. "We are pleased to have been chosen by Unisys to be a part of its Guardian offering and are excited to expand our reach by partnering with a proven secure supply chain leader."
About Unisys
Unisys is a worldwide information technology services and solutions company. Our people combine expertise in consulting, systems integration, outsourcing, infrastructure and server technology with precision thinking and relentless execution to help clients, in more than 100 countries, quickly and efficiently achieve competitive advantage. For more information, visit www.unisys.com.
About GenuOne, Inc.
GenuOne (www.genuone.com) is the leading provider of product tracking software for visibility management. GenuOne's enterprise software enables companies to build and maintain a safe, secure and transparent supply chain. Its flagship product TraceGuard, is the RFID/Barcode infrastructure software to address product authentication, electronic pedigree tracking and asset tracking. Since its inception, GenuOne has tracked hundreds of millions of products across dozens of supply chains spanning more than 14 countries.
RELEASE NO.: 0222/8512
http://www.unisys.com/about__unisys/news_a_events/02228512.htm
Unisys is a registered trademark of Unisys Corporation. All other brands and products referenced herein are acknowledged to be trademarks or registered trademarks of their respective holders.
--30--JO/ph*
CONTACT: Unisys Mike Maney, 215-986-2368 mike.maney@unisys.com or GenuOne, Inc. Alina Halloran, 617-226-3000 ahalloran@genuone.com
KEYWORD: MASSACHUSETTS PENNSYLVANIA INDUSTRY KEYWORD: HARDWARE PHARMACEUTICAL SOFTWARE NETWORKING PRODUCT MARKETING AGREEMENTS SOURCE: Unisys
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Unisys Corp.mehr Nachrichten
06:21 |
Erste Schätzungen: Unisys informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
06.12.24 |
Unisys CEO Peter Altabef To Step Down, COO Mike Thomson To Succeed; Confirms Outlook (RTTNews) | |
28.10.24 |
Ausblick: Unisys stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
15.10.24 |
Erste Schätzungen: Unisys mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
04.08.24 |
Ausblick: Unisys präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu Unisys Corp.mehr Analysen
Aktien in diesem Artikel
Unisys Corp. | 6,40 | 2,14% |